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Internalin A, an internalin protein found in the food-borne pathogen Listeria 
monocytogenes, allows the pathogen to enter host cells through receptor-mediated 
internalization.  Through Internalin A-mediated entry, L. monocytogenes invades 
enterocytes by binding to the receptor protein E-cadherin (Bergmann et al 2002).  In this 
way, the pathogen is able to cross the intestinal barrier, a highly selective permeable 
interface that is responsible for allowing nutrients into the intestinal lumen while barring 
the entry of waste and pathogens.  This study seeks to observe Internalin A-mediated 
entry of a pathogen mimetic system into epithelial cells.  We use polystyrene carboxyl-
terminated microspheres to display Internalin A, study the effect on internalization of 
ligand density and the size of the microsphere.  A pGEX plasmid containing the inlA 
gene, which had previously been purified after transformation into MAX Efficiency 
DH5αF’IQ E. coli competent cells, was transformed into and expressed in OneShot 
BL21(DE3)pLysS E.coli competent cells.  The result of expression of the plasmid was 
the Internalin A protein (InlA), combined with a glutathione S-transferase (GST) tag, in 
order to form a 75 kDa InlA-GST fusion protein.  This fusion protein was subsequently 
purified through affinity chromatography.  Concurrently, a protocol for labeling protein 
with fluorescein isothiocyanate dye (FITC) and covalently coupling the protein to 2 µm 
microspheres was also developed using ovalbumin.  The future steps in this experiment 
are to successfully cleave the GST tag from Internalin A using sequence-specific 
protease, functionalize microspheres with purified InlA labeled with FITC and perform 
internalization studies with microspheres of different sizes and different densities of 
protein coating.  Because InlA can effectively facilitate transport of L. monocytogenes 
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into the cells of the intestinal epithelium, this study has important implications for 






Receptor-mediated internalization is a common mechanism used by intracellular 
pathogens to gain entry into host cells.  Receptor proteins found on host cells play a 
crucial role in mediating cell signaling, cell growth and cell division.  Binding of a ligand 
to a cellular receptor protein initiates signaling pathways in the cell, resulting in changes 
in cellular activity (Alberts and Johnson, 2002).  Ligand binding also plays a key role in 
modulating immune response in host cells, commonly seen in phagocytosis.  After 
binding of pathogen-derived ligands to receptors on the surface of phagocytotic cells, 
these cells form a vesicle called a phagosome that engulfs the pathogen.  Maturation and 
fusion of the phagosome with the lysosome triggers acidification of the phagolysosome, 
which activates degradative enzymes in the lysosome and thus destroys the pathogen 
(Alberts and Johnson, 2002).  While the mechanism and time scale of the steps of 
phagocytosis have been studied extensively in “professional” phagocytotic cells, such as 
macrophages, this process is not well understood in “non-professional” phagocytotic cells 
(Blanchette et al, 2009). 
 After binding of a pathogen-derived protein to a cell surface receptor, the pathogen is 
able to enter the cell.  Immediately after entry, the pathogen is surrounded by a 
phagocytic vacuole that will eventually degrade the pathogen through acidification.  
However, through the concerted action of pathogen enzymes and proteins derived from 
the host cell, the pathogen can then escape the phagocytic vacuole and polymerize the 
free actin of the host cell, thus migrating effectively between cells (Pizarro-Cerda and 
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Cossart, 2006).  Listeria monocytogenes is a prime example of a pathogen that effectively 
invades host cells by binding to cell surface receptors.  Internalin A, a protein found on 
the cell surface of L. monocytogenes, binds to epithelial cadherin (E-cadherin), a cell 
surface receptor found on epithelial cells.  In this way, Internalin A is able to invade 
enterocytes in humans and then polymerize free actin of the host cells to migrate between 
cells (Bergmann et al 2002).  In order to effectively treat diseases caused by intracellular 
pathogens, it is imperative to understand the mechanism of entry of the pathogen.  This 
knowledge can thus be applied to develop a mode of drug delivery that effectively 
facilitates entry of the drug into cells. 
 In Dr. Todd Sulchek’s lab, I have expressed and attempted to purify the InlA-GST 
fusion protein from a pGEX-6P-1-InlA-1 plasmid obtained from Dr. Youn-Hi Woo’s lab.  
This plasmid was previously transformed into and purified from MAX Efficiency 
DH5αF’IQ competent E. coli cells (Invitrogen, Carlsbad, CA).  The purified plasmid was 
transformed into OneShot BL21(DE3)pLysS competent E. coli cells (Invitrogen, 
Carlsbad, CA).  Protein expression was induced with isopropyl β-D-1-
thiogalactopyranoside (IPTG) in transformed BL21(DE3)pLysS cell cultures.  The use of 
BL21(DE3)pLysS cells allowed me to induce transcription because of the nature of the 
DE3 lysogen in these cells.  The DE3 lysogen carries a gene for T7 RNA polymerase.  T7 
RNA polymerase is under control of the lacUV5 promoter, whose transcription is 
inducible with the addition of IPTG (Invitrogen, 2010).  Absorbance readings were taken 
to determine the growth phase of the cell cultures, and transcription of T7 RNA 
polymerase was thus induced when the cell cultures reached the mid-log phase of growth.  
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In this way, protein yield could be maximized and transcription was induced in healthy 
and viable cells. 
 Protein was subsequently purified through affinity chromatography.  I used 
Glutathione Spin Columns (Pierce, Rockford, IL) because of GST’s high binding affinity 
for glutathione (Blanchette et al, 2009).  The InlA-GST protein was subsequently 
displaced from the column with excess reduced glutathione, leading to elution of the 
fusion protein from the column (ThermoScientific, 2010).  A BCA assay was used to 
quantify the concentration of protein in solution.  Cu
2+
 ions are reduced to Cu
1+
 ions 
through the Biuret reaction, in which copper is chelated with protein in an alkaline 
medium (ThermoScientific, 2010).  The colorimetric nature of the BCA assay is 
dependent on the detection of Cu
1+
 ions by bicinchoninic acid.  In order to account for the 
presence of reducing agents, such as diothreithol and glutathione, in the InlA-GST fusion 
protein solution, a Reducing Agent Compatible Microplate BCA Assay Kit (Pierce, 
Rockford, IL) was used.            
 I have also concurrently labeled ovalbumin with FITC and functionalized 2 µm 
polystyrene carboxyl-terminated microspheres with FITC-labeled ovalbumin (FITC-
OVA).  These functionalized microbeads can be used as a negative control in future steps 
of the experiment, when performing internalization assays with InlA-functionalized 
microbeads.  In addition, I chose to use ovalbumin when developing the protocol for the 
functionalization of microbeads because ovalbumin has a molecular weight of 45 kDa.  
This is comparable to the molecular weight of InlA, which is 50 kDa, meaning that 
microspheres have similar binding capacities for both of these proteins and the same 
mass of protein may be used to effectively functionalize the microspheres.  This makes it 
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easy to use the same protocol developed for binding FITC-OVA to microspheres when 
functionalizing the microspheres with InlA.      
 Future steps in this experiment include cleaving the GST tag from the fusion 
protein with protease, labeling the purified InlA with FITC and covalently coupling the 
labeled protein to microspheres.  After this, internalization assays will be conducted with 
Caco-2 cells using flow cytometry and fluorescence microscopy in order to observe the 
effect of InlA functionalization, bead size and density of protein bound the microspheres 
on microsphere internalization.   
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CHAPTER 2 
BACKGROUND INFORMATION AND LITERATURE REVIEW 
Cells rely heavily on cell surface receptor proteins to regulate cell signaling, cell 
growth and cell division.  Binding of a ligand to a cell surface receptor typically elicits 
changes in the cell and commonly initiates signal transduction pathways in the cell.  In 
this way, factors of the extracellular environment can modulate gene expression and 
intracellular protein activity.  A prime example of a cell surface receptor is epithelial 
cadherin, or E-cadherin.  E-cadherin is a cell adhesion molecule (CAM) that regulates 
Ca
2+
 adhesion of adjacent cells, playing a crucial role in cell signaling and embryonic 
development (Alberts and Johnson, 2002).   
Because of the high affinity of ligands for particular cell surface receptors, 
receptor proteins also play a key role in recognition of pathogens and initiation of 
appropriate immune responses, such as phagocytosis.  After binding of pathogen-derived 
ligands to receptors on the surface of phagocytotic cells, these cells form a vesicle, called 
a phagosome, which engulfs the pathogen (Cooper, 2000).  Maturation and fusion of the 
phagosome with the lysosome triggers acidification of the phagolysosome, which 
activates degradative enzymes in the lysosome and thus destroys the pathogen (Cooper, 
2000).  This mechanism is has been studied and is well understood in cells whose 
primary function is phagocytosis (e.g. macrophages and neutrophils), or “professional” 
phagocytes.  However, phagocytosis also occurs as a secondary function in other cells, 
called “nonprofessional” phagocytes, and these cells are more limited in the types of 
molecules that they can engulf.  It is in these cells that receptor-mediated internalization 
of intracellular pathogens commonly occurs.  It is known that intracellular pathogens 
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such as Yersinia enterocolitica and Listeria monocytogenes are not only able to 
effectively invade host cells through binding of surface proteins to host cell surface 
receptors, but are also able to evade host immune responses (Bogdan, 2008).  Although 
the process of invading host cells is an energetically demanding process for the pathogen, 
the pathogen is able to safely and successfully reproduce inside the host cell and keep its 
metabolic demands to a minimum by parasitizing the host cell (Bogdan, 2008).        
L. monocytogenes, a Gram-positive bacteria and food-borne pathogen commonly 
found in produce and undercooked meat, invades cells through host cell surface receptor 
interaction with a family of proteins called internalins.  The internalin family of proteins 
is characterized by binding of the protein to the cell surface receptor of the host through 
leucine-rich repeat domains.  The two best-understood mechanisms of internalization of 
L. monocytogenes in mammalian cells are mediated by Internalin A and by Internalin B 
(Lecuit, 2005).  These two surface proteins interact with different host cell surface 
receptors in order to promote entry of L. monocytogenes. Internalin B binds to the Met 
receptor, a tyrosine kinase receptor located on hepatocytes.  Thus, Internalin B-mediated 
listeriosis manifests itself as liver infection (Gaillard et al., 1991).  Internalin A, on the 
other hand, binds to E-cadherin in intestinal epithelial cells facilitating entry of the 
pathogen into the intestinal lumen.  After gaining entry to host cells, L. monocytogenes is 
engulfed in a phagocytotic vacuole, but is able to escape through expression of the 
protein listeriolysin.  After successful evasion of the host cell’s immune response, L. 
monocytogenes migrates between cells by polymerizing the host cell’s free actin through 
expression of the actA protein, thus allowing the pathogen to cross biological barriers 
(Lecuit, 2005).  In this way, L. monocytogenes is capable of traversing the fetoplacental 
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barrier, possibly leading to spontaneous abortion in infected pregnant women.  In the 
most serious cases of listeriosis, L. monocytogenes can cross the blood-brain barrier, 
leading to meningitis and shutdown of the central nervous system if left untreated (Ireton 
2007).   
 Studying the mechanism of internalization via Internalin A as well as the factors 
that affect the success of L. monocytogenes’s entry into human cells is important because 
this research has important implications for drug delivery.  The intestinal barrier is a 
highly selectively permeable interface that is responsible for delivering nutrients to the 
intestinal lumen and for barring the entry of pathogens.  The integrity of the permeability 
of the intestinal barrier is extremely important in maintaining health.  Although the 
intestinal barrier prevents pathogens from entering the intestine, it makes the transport 
and delivery of larger agents, such as proteins and capsulated particles, more difficult.  
This also hinders efficient delivery of drugs into the intestine ((Ashkan Farhadi 2003).  
However, certain pathogens are able to bind to mucins on the on the surface of mucosal 
epithelial cells, allowing them to permeate the intestinal barrier as well as internalize in 
epithelial cells in the intestine (Linden et al 2004).  Taking advantage of the capabilities 
of Internalin A to successfully internalize in host cells is a starting point for improving 
the efficiency of drug delivery to the intestinal lumen. 
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CHAPTER 3 
MATERIALS AND METHODS 
pGEX-6p-1-InlA-1 Plasmid Purification 
Prior to this experiment, the pGEX-6P-1-InlA-1 plasmid was obtained from Dr. 
Youn-Hi Woo, and was transformed into MAX Efficiency DH5αF’1Q E. coli competent 
cells (Invitrogen, Carlsbad, CA).  Following transformation, the plasmid was purified 
using a Plasmid Purification Midi Kit (QIAGEN, Valencia, CA).  Successful purification 
of the plasmid was confirmed by agarose gel electrophoresis.  
BL21(DE3)pLysS Plasmid Transformation 
Transformation of the plasmid into BL21(DE3)pLysS competent E. coli cells was 
performed according to the manufacturer’s protocol.  Two vials of cells were thawed, and 
only one of these two vials was transformed.  10 ng of the purified pGEX-6P-1-InlA-1 
plasmid was added to one vial of cells, and the vial was incubated on ice for 30 minutes.  
The vials were then heat shocked for 30 seconds in a 42°C water bath and placed on ice.  
After heat shock, the vial was incubated at 37°C with 250 µL of S.O.C medium, provided 
with the cells, and shaken for one hour at 225 rpm.  The transformed cells were then 
plated onto LB plates with 34 µg/mL chloramphenicol and 50 µg/mL ampicillin.  The 
pLysS plasmid found in the BL21(DE3)pLysS cells endows the cells with 
chloramphenicol resistance, and the pGEX plasmid confers ampicillin resistance.  Thus, 
competent E. coli cells transformed with the pGEX-6P-1-InlA-1 plasmid would be 
expected to grow successfully on plates containing chloramphenicol and ampicillin, 
whereas untransformed cells would not be able to grow on these plates.  Untransformed 
BL21(DE3)pLysS cells were plated onto LB plates containing 34 µg/mL 
 9 
chloramphenicol, in order to verify the functionality of the pLysS plasmid, as well as LB 
plates without antibiotics to test for phage contamination.  The plates were then incubated 
overnight at 37°C. 
Internalin A Gene Expression 
Four colonies from the plate containing BL21(DE3)pLysS cells transformed with 
the pGEX-6P-1-InlA-1 plasmid were inoculated in 5 mL of LB media with 50 µg/mL 
ampicillin.  This was done in order to select for successful transformants in the liquid 
cultures as well as the previously described plated transformation reactions.  Four of 
these starter cultures were shaken overnight, at 37°C and 225 rpm.  These cultures were 
then diluted in 250 mL of LB media and shaken again at 37°C and 225 rpm.  Absorbance 
was monitored at 600 nm in order to find the mid-log phase of growth and determine the 
correct time to add IPTG to induce expression of the InlA gene in the cultures.  When 
A600 was determined to be in the 0.4 to 0.6 range, IPTG was added and the cultures were 
shaken for another four hours.  Further cell growth was stopped by placing the flasks on 
ice, and the cultures were then centrifuged for 30 minutes at 5000 rpm.  Cell pellets were 
subsequently collected and stored at -20°C before protein purification.   
Internalin A Protein Purification 
Cell pellets were first lysed with B-PER Bacterial Protein Extraction Reagent, 
purchased from Pierce (Rockford, IL).  Halt Protease Inhibitor Cocktail was purchased 
from Pierce (Rockford, IL) and added to the cell lysate at a concentration of 10 µL per 
mL of cell lysate.  EDTA was also added at 10 µL per mL of cell lysate in order to inhibit 
metalloprotease activity.  The cell pellets were weighed and then suspended in 4 mL of 
B-PER Bacterial Protein Extraction Reagent per gram of cell pellet.  After incubating the 
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cell pellets with the B-PER Bacterial Protein Extraction Reagent for 15 minutes, the 
lysate was then centrifuged at 15000 g for 30 minutes in order to separate the soluble 
Internalin A-GST fusion protein from insoluble protein in the cell lysate.  In this step, the 
insoluble protein was pelleted while Internalin A and other soluble protein was collected 
in the supernatant.  The supernatant from this step was then combined with an equal 
amount of Equilibration/Wash Buffer and applied to 1 mL Glutathione Spin Columns.  
Both of these items were purchased from Pierce (Rockford, IL).  Before applying the 
lysate to the columns, however, the GST spin purification columns were prepared by 
washing the resin with 2 mL of Equilibration/Wash buffer. 
The cell lysate was incubated with the GST spin purification column for one hour 
before centrifugation.  Unbound protein was collected in the flowthrough from 
centrifugation of the column and was washed off of the column using 1 resin bed volume 
of Equilibration/Wash buffer.  The absorbance of the elute was monitored at 280 nm to 
confirm the presence of protein in solution.  To equilibrate the column and facilitate 
effective binding of protease for the cleavage step, the column was washed with 1 resin 
bed volume (1 mL) of Cleavage Buffer, composed of 1 M PBS, 1 mM diothreithol (DTT) 
and 1 mM EDTA.  80 µL of Prescission Protease, purchased from GE, was combined 
with 920 µL Cleavage Buffer, applied to the column and shaken for four hours at 4° C.  
After incubation of the column with the protease, the column was then centrifuged in 
order to collect the protein of interest.  At this point, we can expect the Prescission 
Protease to have successfully cleaved the bond between Internalin A and the attached 
GST tag, thus allowing us to elute Internalin A from the column by centrifugation and 
leaving the GST tag bound to the spin column.  Subsequently, any Internalin A remaining 
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on the column was eluted with 1 resin bed volume of Equilibration/Wash buffer, and the 
absorbance of the elute was monitored at 280 nm to confirm the presence of protein in 
solution.  GST was eluted from the column using Elution Buffer, consisting of 1 mL of 
10X glutathione stock solution diluted in 9 mL of Equilibration/Wash Buffer.      
SDS-PAGE and Coomassie Staining 
Samples from steps in the protein purification protocol were analyzed using SDS-
PAGE, in order to confirm the presence of Internalin A in solution.  One Precise Protein 
Gel from Pierce (Rockford, IL) was inserted into a PAGE insert, which was then placed 
in a gel tank.  The inner chamber and the gel tank were then filled with Tris-HEPES-SDS 
buffer.  Samples were prepared by adding 5 µL Lane Marker Reducing Sample Buffer 
(Pierce, Rockford, IL) to 20 µL protein sample, denaturing the samples by heating them 
in 100°C water for 3-5 minutes, centrifuging the samples at 6300 rpm for 3 minutes and 
then collecting the supernatant.  10 µL of Spectra Multicolor Broad Range Protein 
Ladder (Pierce, Rockford, IL) were added to the first well.  25 µL of prepared samples 
from the elution of unbound proteins, the Cleavage Buffer elution step, the 
Equilibration/Wash buffer elution step, and the GST elution step were added to the next 
four wells.  After loading the samples, the gel was run for 90 minutes at 110 V and 45 
mA, until the dye front from the Lane Marker Reducing Sample Buffer was 0.5 cm away 
from the bottom of the gel.     
After the run time was completed, the gel was washed three times with DI water 
to remove SDS, and was then stained with 20 mL of GelCode Blue Stain Reagent 
solution (Pierce, Rockford, IL) for 1 hour.  The gel was then destained by shaking the gel 
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with DI water for 2 hours.  Band intensity was monitored and the water was changed 
several times over the course of destaining. 
Dialysis 
In order to increase the concentration of protein in solution, the samples were 
dialyzed using Pierce 10K Molecular Weight Cutoff Protein Concentrators (Pierce, 
Rockford, IL).  Concentrators with a molecular weight cutoff of 10000 Da were used 
because the molecular weight of InlA is 50 kDa, and the protein of interest must have 
more than twice the molecular weight of the molecular weight cutoff of the concentrators 
being used.  The concentrator was inserted into a collection chamber and the membrane 
of the concentrator was rinsed with DI water.  500 µL of the protein sample was applied 
to the concentrator and centrifuged at 15000 g until the volume of protein sample in the 
concentrator was 100 µL.  The retentate was then aspirated carefully from the 
concentrator using a 10 µL pipette, so as not to damage the concentrator membrane.  
Bicinchoninic Acid Assay 
The concentration of Internalin A in solution before and after dialysis was 
quantified by performing a BCA assay.  DTT and glutathione are known reducing agents 
that interfere with the production of Cu
1+
 ions in the Biuret reaction, which are detected 
by bicinchoninic acid and cause the color change of solution in the presence of protein.  
Therefore, I used the Reducing Agent Compatible BCA Protein Assay Kit from Pierce 
(Rockford, IL).  The concentration of protein in solution was determined by following the 
manufacturer’s protocol.  A Standard Control and Sample Control were prepared, and 
were differentiated by the presence of reducing agent.  While the Sample Control was the 
same buffer as that of the protein samples, the Standard Control did not contain the 
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reducing agent and was used as a blank.  BSA standards were diluted in the same buffer 
as the Standard Control (i.e. the same buffer as that of the samples without the reducing 
agent) to create protein solutions with concentrations ranging from 125 µg/mL to 2000 
µg/mL BSA.  The concentrations and volumes of diluent and BSA solution in each 
standard can be found in Table 1.  9 µL samples of Sample Control, Standard Control, 
BSA standard and Internalin A solution were added in a microplate to 4 µL of 
Compatibility Reagent Solution, which was provided with the kit in order to modify 
disulfide reducing agents to minimize interference with the assay.  After shaking the 
microplate for one minute, the samples were incubated at 37°C for 15 minutes.  After 
incubation, kit-provided Working Reagent was added to the samples in order to begin the 
process of detecting Cu
1+
 ions, and the samples were incubated at 37°C for 30 minutes.  
After cooling the microplate to room temperature, the absorbance of the samples, 
standards and controls was measured at 562 nm.  A standard curve was generated by 
plotting the blank-corrected absorbance values for the standards against the 
concentrations of the standards in µg/mL, and was used to calculate the concentration of 
Internalin A in solution. 
Labeling of Protein with FITC 
  While expressing and purifying the Internalin A protein, I simultaneously 
attempted to successfully bind FITC-labeled protein to microspheres in preparation for 
internalization studies with Caco-2 cells.  In addition to InlA-conjugated microspheres 
and microspheres labeled only with FITC, protein-conjugated microspheres that could 
serve as a negative control would be required for internalization studies.  Ovalbumin was 
used as a negative control because this protein has no internalization capabilities.  Imject 
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Ovalbumin was purchased from Pierce (Rockford, IL) and labeled with FITC using the 
FluoReporter™ FITC Protein Labeling Kit from Life Technologies (Grand Island, NY).  
Ovalbumin was labeled following the manufacturer’s protocol.  After calculating the 
volume of reactive dye stock solution required to label the ovalbumin solution, a reaction 
tube was prepared by adding 20 µL of freshly prepared 1M sodium bicarbonate solution 
to 200 µL of ovalbumin solution.  Immediately before beginning the labeling reaction, 37 
µL of dimethylsulfoxide (DMSO) was added to the FITC dye stock solution.  The 
labeling reaction was stirred for one hour and was kept protected from light. 
After the labeling reaction was complete, FITC-OVA was then purified using spin 
columns provided in the labeling kit.  The conjugate was first centrifuged in order to 
dispose of any precipitate, and was then loaded dropwise onto the spin column and 
centrifuged again.  The resulting flowthrough was comprised of FITC-OVA suspended in 
approximately 250 µL of PBS and 2 mM sodium azide, in order to protect the conjugate 
from bacterial contamination.  The concentration of protein and degree of labeling of the 
resultant conjugate was then calculated, and the conjugate was stored in aliquots at -20°C.      
Conjugation of FITC-OVA to Microspheres 
Immediately after labeling, FITC-OVA was bound to 2 µm and 0.5 µm carboxyl-
terminated microspheres.  The amount of protein required to form a monolayer on the 
microspheres was calculated based on the density and diameter of the microspheres as 
well as the capacity of the microsphere surface to bind the protein.  The capacity of the 
microsphere surface to bind a particular protein is a constant that is related to the 
molecular weight of the protein.  Capacities for two proteins, bovine serum albumin 
(BSA) and bovine IgG (BIgG), were found to be 3 mg/m
2
 and 2.5 mg/m
2
 respectively.  
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The molecular weight of BSA is 65 kDa, whereas the molecular weight of BIgG is 150 
kDa.  The molecular weight of ovalbumin, which is 45 kDa, is more comparable to the 
molecular weight of BSA than that of BIgG.  Therefore, the capacity of the microspheres 
to bind ovalbumin was approximated to be equal to 3 mg/m
2
.   
Subsequently, the mass of microspheres per microliter of microsphere suspension 
was calculated by using the percent solid, and this mass was then used to calculate the 
total mass of protein needed to saturate the microspheres.  It is recommended that a 3-
10X excess of the calculated mass of protein required to form a monolayer is incubated 
with the microspheres in order to increase specificity of binding and to make sure the 
protein is correctly spatially oriented.  Therefore, a fourfold excess of protein was 
covalently coupled to 50 µL of 2 µm microbeads, using 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysulfosuccinimide (Sulfo-
NHS).  50 µL of microbeads were diluted with 950 µL of MilliQ water.  After 
centrifugation at 3600 rpm for 15 minutes, the supernatant was removed and the beads 
were resuspended in 0.1 M MES 0.8% NaCl buffer with a pH of 4.7.  2-(N-morpholino) 
ethanesulfonic acid (MES) was used as an activating agent in order to increase efficiency 
of coupling of the labeled protein to the microbeads.  1 mg of EDC and 1 mg of Sulfo-
NHS were added to the bead suspension, incubated at room temperature for 20 minutes 
and centrifuged again.  After resuspension of the bead solution in water and subsequent 
centrifugation, the beads were resuspended in PBS with 11.9 µL of FITC-OVA and 
incubated for two hours.  Subsequently, any unbound protein was discarded by washing 





10 ng of the purified pGEX-6P-1-InlA-1 plasmid was transformed into one vial of 
BL21(DE3)pLysS cells.  This transformation reaction was then plated in 50 µL and 150 
µL volumes onto two LB plates containing 50 µg/mL ampicillin and 34 µg/mL 
chloramphenicol in order to select for viable transformants expressing the pLysS plasmid, 
which confers chloramphenicol resistance, as well as the pGEX-6P-1-InlA-1 plasmid, 
which confers ampicillin resistance.  White colonies were observed on both of these 
plates, confirming viability of the BL21 cells as well as successful transformation with 
the pGEX-6P-1-InlA-1 plasmid.  As expected greater number of colonies were observed 
on the 150 µL plate than on the 50 µL plate.  However, the colonies on the 50 µL plate 
were larger in diameter than the colonies on the 150 µL plate, as portrayed in Figure 1A 
and 1B.   
Untransformed BL21(DE3)pLysS cells were plated onto three LB plates: one that 
did not contain antibiotics in order to verify a lack of phage contamination, one with 50 
µg/mL ampicillin in order to verify a lack of ampicillin resistance contamination, and one 
with 34 µg/mL chloramphenicol in order to verify viability of the cells and expression of 
the pLysS plasmid.  Lawn growth was observed on the plates containing 34 µg/mL 
chloramphenicol and no antibiotics, and no growth was observed on the plate containing 














Figure 1. Plating of BL21(DE3)pLysS cells. A) 150 µL transformed BL21(DE3)pLysS cells.  B) 50 µL transformed 
BL21(DE3)pLysS cells.  C) 50 µL untransformed BL21(DE3)pLysS cells on LB without antibiotics. D) 50 µL 
untransformed BL21(DE3)pLysS cells on LB with 34 µg/mL chloramphenicol. E) 50 µL untransformed 






SDS-PAGE was conducted in order to verify expression of the pGEX-6P-1-InlA-






























C A B D E F 
Figure 2. SDS-PAGE of samples from protein purification.  Well A) Spectra Multicolor Broad 
Range Protein Ladder (Pierce).  Well B) Unbound protein from transformed BL21(DE3)pLysS cell 
lysate in Equilibration/Wash buffer elute.  A weak 75 kDa band can be seen in this sample, as well as 
weak protein bands ranging from 10 kDa to 260 kDa.  A very strong 40 kDa band is also present in 
this sample.  Well C) Cleavage Buffer elution of InlA using Prescission Protease.  The absence of 
bands in this well indicates that no protein was eluted in this wash.  Well D) Equilibration/Wash 
buffer elution of remaining InlA.  The absence of bands in this well indicates that no protein was 
eluted in this wash.  Well E) Elution Buffer wash step.  In this step, GST was eluted from the column 
with glutathione.  A 75 kDa and 40 kDa band were detected in this elute.  The 75 kDa band is 
slightly stronger than that in Well B.  Background protein bands are also observable, but are weaker 
than those in Well B.  Well F) Elution Buffer wash solution after dialysis.  All protein bands 
observed in Well E are stronger in Well F, indicating successful concentration of the protein solution.              


















BSA standards were created by serial dilutions using the volumes of diluents and 
BSA described in Table 1, in order to generate standards with concentrations ranging 
from 125 µg/mL to 2000 µg/mL.  A standard curve was generated by plotting the 








A 0 200 2000 
B 66 200 1500 
C 100 100 1000 
D 100 100 750 
E 100 100 500 
F 100 100 250 
G 100 100 125 















Figure 3. BCA assay standard curve generated by plotting corrected A562 against protein 
solution concentration.  The line of best fit associated with the curve has a coefficient of 
determination of 0.9955. 
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Because the presence of Internalin A-GST fusion protein in the GST elution step was 
confirmed by SDS-PAGE, the equation of the line of best fit was used to calculate the 
concentration of protein in this elute before and after dialysis.  A562 of the Elution Buffer 
elute before dialysis was found to be 0.261, and A562 of the Elution Buffer elute after 
dialysis was found to be 0.454.  The concentration of protein in solution before dialysis 
was calculated to be 272.7 µg/mL (Equation 1) and the concentration of protein in 
solution after dialysis was 548.4 µg/mL (Equation 2).   
                     
Equation 1. Calculation of concentration of protein in the Elution Buffer elute before dialysis.  The concentration of 
protein in solution was calculated to be 272.7 µg/mL.   
                     
Equation 2. Calculation of concentration of protein in the Elution Buffer elute after dialysis.  The concentration of 





























Labeling of Ovalbumin with FITC 
After labeling ovalbumin with FITC, the concentration of protein in solution was 
calculated by measuring the absorbance of the protein conjugate at 494 nm and 280 nm 
(Equation 3).  Absorbance of the conjugate was measured at 494 nm because this is the 
maximum absorption wavelength for FITC.  The molarity of the protein solution was 
subsequently used to calculate the degree of labeling of the protein (Equation 4).       
 
              
                                 
 
 
                     
     
            
Equation 3. Calculation of final concentration of FITC-OVA in solution.  The molar extinction coefficient 
of ovalbumin is denoted by   and was given to be 24000.  0.3 is a correction factor used to correct the A494 




                                     
                     
                
 
       
              
      
Equation 4. Calculation of degree of labeling of protein.  The molar extinction coefficient of FITC at 494 



























Conjugation of FITC-OVA to Microspheres 
 The mass of protein required to form a monolayer on 1 gram of 
polystyrene-based microspheres was calculated based on the density and diameter of the 
microspheres as well as the capacity of the microsphere surface to bind the protein 
(Equation 3).  The density of polystyrene is 1.05 g/cm
3
, and the capacity of the 
microspheres to bind ovalbumin was estimated to be 3 mg/m
2
 (Bangs Laboratories).  
Using these constants, the mass of protein required to saturate 1 gram of 2 µm 
microspheres was calculated to be 8.57 mg.  The percent solid of the microspheres was 
10.05%.  This percent solid was used to calculate the total mass of spheres present in 50 
µL of suspended microspheres and the mass of protein needed to saturate the 
microspheres was calculated to be 0.043 mg (Equation 4).  Finally, a fourfold excess of 
protein was incubated with the microspheres during conjugation, and the volume of 
protein solution required was determined to be 11.9 µL (Equation 5).  Successfully 
covalent coupling of FITC-OVA to the microspheres can be observed in Figure 4.     
   
 
  
     
Equation 5. Mass of protein required to saturate one gram of 2 µm microspheres.  In this equation, ρ 
represents the density of the microspheres, D represents the diameter of the microspheres in micrometers, 




              
  
      
   
      
 
              
       
                  




                   
   
               
 
       
  
                  









 The use of BL21(DE3)pLysS E. coli competent cells affords us the ability 
to control the timing of gene expression because of the presence of the DE3 lysogen in 
these cells.  The DE3 lysogen carries the gene for T7 RNA polymerase, whose expression 
is regulated by the lacUV5 promoter.  Transcription of the lacUV5 promoter is inducible 
in the presence of isopropyl β-D-1-thiogalactopyranoside (IPTG).  In this way, protein 
yield can be maximized by inducing transcription of T7 RNA polymerase during the mid-
log phase of exponential bacterial growth.  Lawn growth of untransformed cells and an 
absence of clear patches were observed in the absence of antibiotics, thus confirming a 
lack of phage contamination of the cells.  Lawn growth of untransformed cells was also 
observed in the presence of chloramphenicol.  Because the pLysS plasmid confers 
chloramphenicol resistance, untransformed cells are expected to grow in the presence of 
chloramphenicol, and this plate confirms the integrity of the pLysS plasmid.  The absence 
of growth observed in the presence of ampicillin confirms a lack of ampicillin resistant 
contamination.  The pLysS plasmid does not confer ampicillin resistance; thus, growth of 
BL21(DE3)pLysS cells would not have been expected unless they had been transformed 
with a plasmid that does confer ampicillin resistance.  Successful transformation of the 
BL21(DE3)pLysS cells with the pGEX-6P-1-InlA-1 plasmid was confirmed by observing 
growth of the transformed cells in the presence of both chloramphenicol and ampicillin.  
However, colonies formed by transformed cells on the 50 µL plate were larger than those 
formed by the transformed cells on the 150 µL plate.  This disparity in size may be due to 
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the fact that the plates were taken out of the incubator and stored at 4°C earlier than 
recommended. 
 After purification of the protein, expression of the InlA-GST fusion 
protein was confirmed by the 75 kDa band observed in the Elution Buffer elute from the 
GST elution step.  The molecular weight of InlA is 50 kDa, and the molecular weight of 
GST is 25 kDa.  Thus, this confirms that the fusion protein is still intact and was not 
successfully cleaved with the PreScission Protease.  In addition, no protein was eluted 
during the Cleavage Buffer elution step or the subsequent Equilibration/Wash buffer 
elution step, also indicating that the protease did not cleave the bond between the GST 
tag and InlA, and that the fusion protein was still bound to the column before elution with 
glutathione.  This means that after the column was washed with Elution Buffer, the 
excess glutathione in the Elution Buffer led to washing of the GST off of the column, 
resulting in elution of the entire fusion protein in this step.  
 In order to increase the concentration of InlA-GST fusion protein in 
solution, the Elution Buffer elute was dialyzed using Pierce Protein Concentrators with a 
molecular weight cutoff of 10000 Da.  A BCA assay was performed to calculate the 
concentration of protein in solution.  Because the concentration of protein in solution is 
higher in the protein sample after dialysis than before dialysis, dialysis was successful.  
However, its efficiency could have been improved because in the SDS-PAGE fraction of 
the dialyzed protein sample, a strong 40 kDa protein band was observed in solution.  This 
is because the 40 kDa fragment has a molecular weight of more than twice the molecular 
weight cutoff of the protein concentrator and was thus retained in the concentrator rather 
than being filtered out.  However, by aiming to dialyze the InlA-GST fusion protein and 
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cleave the bond between the GST tag and InlA in solution rather than elute InlA off of 
the glutathione spin column with the protease, the molecular weight cutoff of the protein 
concentrators used could be increased.  Because the molecular weight of InlA-GST is 75 
kDa, protein concentrators with a molecular weight cutoff of 30 kDa could be used 
instead, thus increasing the specificity of dialysis and increasing the purity of the protein 
in solution. 
 Ovalbumin was chosen as a negative control because its molecular weight 
is comparable to that of InlA.  Therefore, ovalbumin and InlA have comparable 
adsorption capacities to polystyrene microbeads, but ovalbumin is a storage protein, and 
it is therefore unlikely that it would be involved in receptor mediated entry.  I chose to 
label ovalbumin with FITC before coupling the protein to microspheres in order to be 
able to observe coupling of the protein to the microspheres through fluorescent 
microscopy.  Because the uncoupled polystyrene beads do not have inherent 
fluorescence, the presence of fluorescence on the beads indicates successful coupling of 
protein to the microspheres.  In addition, there is very little fluorescence in the buffer 
surrounding the microspheres, indicating that unbound FITC-OVA was successfully 
washed off of the microspheres.  The degree of labeling of the ovalbumin solution was 
found to be 0.48 molecules of FITC per protein molecule.  The optimal degree of labeling 
is 4-8 molecules of FITC per protein molecule (Invitrogen).  However, this value is 
optimal for labeling of antibodies, which have significantly higher molecular weights 
than ovalbumin.  While the optimal degree of labeling for ovalbumin is very likely 
smaller than the value recommended by Invitrogen, a future step for optimizing this 
protocol would be to perform labeling reactions with varied molar ratios of dye to 
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protein, in order to find the optimal molar ratio of dye to protein that should be used 
when labeling ovalbumin.       
 Even though Internalin A has not been successfully purified yet, the described 
protocol for labeling ovalbumin with FITC and binding FITC-OVA to microspheres can 
be used for Internalin A as well.  This is because the capacity of the microsphere to bind 
a particular protein is a principal factor in determining the mass of protein required to 
saturate 1 gram of microspheres, and varies based on the molecular weight of the protein 
in question.  The capacity of polystyrene microspheres to bind ovalbumin was estimated 
based on the molecular weight of BSA, which is 65 kDa.  The molecular weight of 
ovalbumin is 45 kDa, and is comparable to that of InlA, which is 50 kDa.  
 Future steps for this project include eluting the InlA-GST fusion protein and 
incubating the fusion protein with PreScission Protease in solution in order to verify 
functionality of the protease, rather than applying the protease to the column.  The first 
step required is to successfully purify the InlA protein.  After functionalizing 
microspheres with FITC-labeled and purified InlA, the microspheres will be incubated 
with Caco-2 cells, which have already been obtained from Dr. Andrew Neish’s lab.  
Internalization efficiency will be observed in InlA-functionalized microspheres and 
compared to ovalbumin-functionalized microspheres and microspheres conjugated only 
with FITC, in order to elucidate the effect of the presence of InlA on entry of 
microspheres into human cells.  The effect of ligand density and bead size on 
internalization of microspheres will also be observed using fluorescent microscopy and 
flow cytometry.  By performing internalization studies and observing success of 
Internalin A-mediated entry of microspheres in various epithelial cell lines, we can 
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progress towards creating a more efficient system of drug delivery to the intestinal lumen.  
Using receptor-mediated internalization to deliver drugs to the intestinal epithelium could 
increase the rate of success with which drugs are able to cross the selectively permeable 
barrier of the intestinal epithelium, thus increasing efficiency and success of treatment 





Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New 
            York: Garland Science; 2002. Cell Biology of Infection. Available from: 
             http://www.ncbi.nlm.nih.gov/books/NBK26833/ 
 
Ashkan Farhadi, A. B., Jeremy Fields, Ali Keshavarzian (2003). "Intestinal barrier: An 
interface between health and disease." Journal of Gastroenterology and 
Hepatology 18(5): 479-497. 
 
Bergmann, B., et al. (2002). "InlA- but not InlB-mediated internalization of Listeria 
monocytogenes by non-phagocytic mammalian cells needs the support of other 
internalins." Mol Microbiol 43(3): 557-570. 
 
Blanchette, C. D., et al. (2009). "Decoupling Internalization, Acidification and 
Phagosomal-Endosomal/lysosomal Fusion during Phagocytosis of InlA Coated 
Beads in Epithelial Cells." PLoS ONE 4(6): e6056. 
 
Bogdan, C. (2008). "Mechanisms and consequences of persistence of intracellular 
pathogens: leishmaniasis as an example." Cell Microbiol 10(6): 1221-1234. 
 
Bonazzi, M., et al. (2009). "Listeria monocytogenes internalin and E-cadherin: from 
structure to pathogenesis." Cell Microbiol 11(5): 693-702. 
 
Cooper GM. The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer 
Associates; 2000. Functions of Cell Surface Receptors. Available from: 
http://www.ncbi.nlm.nih.gov/books/NBK9866/ 
 
Gaillard, J.-L., Berche, P., Frehel, C., Gouin, E., and Cossart, P. L. monocytogenes  in 
mice. J. Comp. Pathol. 107, 1–9. 
(1991). Entry of L. monocytogenes  into cells is mediated by internalin, a repeat 
protein reminiscent of surface antigens from gram positive cocci. Cell 65, 1127 
1141 
 
Invitrogen Corporation One Shot® BL21(DE3), One Shot® BL21(DE3)pLysS, One Shot® 
BL21(DE3)pLysE, Competent Cells. (2010) Carlsbad, CA. 
 
Ireton, K. (2007). "Entry of the bacterial pathogen Listeria monocytogenes into 
mammalian cells." Cell Microbiol 9(6): 1365-1375. 
 
Lecuit, M. (2005). "Understanding how Listeria monocytogenes targets and crosses host 




Lindén, S. K., et al. (2008). "Listeria monocytogenes internalins bind to the human 
intestinal mucin MUC2." Archives of Microbiology 190(1): 101-104. 
 
ThermoScientific Corporation Pierce® Microplate BCA Protein Assay Kit –  
Reducing Agent Compatible. (2010) Rockford, IL. 
 
ThermoScientific Corporation Thermo Scientific Pierce® Protein Purification Technical 
Handbook. (2010) Rockford, IL. 
 
 
 
 
 
